Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.81 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.81 |
| ▸ | POLH | Q9Y253 | 4/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.81 |
| ▸ | POLB | P06746 | 2/20 | 0.81 |
| ▸ | APEX1 | P27695 | 2/20 | 0.81 |
| ▸ | RECQL | P46063 | 2/20 | 0.81 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | MMP1 | P03956 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17102291 | 0.90 | POLH (0.82) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| Isokaempferide SCHEMBL1628023 | 0.90 | POLH (1.00) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| Isokaempferide SCHEMBL29721227 | 0.90 | POLH (1.00) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL27093588 | 0.88 | POLH (0.67) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL28664318 | 0.88 | TUBB4A (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL18923490 | 0.84 | POLH (0.76) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL30627918 | 0.84 | CYP3A4 (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL21376116 | 0.84 | POLH (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL21375998 | 0.84 | POLH (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB | |
| SCHEMBL30627917 | 0.84 | CYP3A4 (0.75) | CYP3A4CYP2D6POLHKDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195138-A1 | Anti-inflammatory cranberry flavonol extract preparations | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2011-08-11 | — | — | US | disclosed |
| US-20070292539-A1 | Anti-inflammatory cranberry flavonol extract preparations | VORSA NICHOLI | 2007-12-20 | — | — | US | disclosed |
| US-7270837-B2 | free of anthocyanins and proanthocyanidins; treatment of inflammatory disorders, particularly irritation of the urinary tract due to both bacterial and non-bacterial causes | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2007-09-18 | — | — | US | disclosed |
| US-20060088610-A1 | Anti-inflammatory cranberry flavonol extract preparations | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292539-A1 | Anti-inflammatory cranberry flavonol extract preparations | LGALS3, FUT6, GALNT6 | CYP3A4 1687/4885CYP2D6 461/4885POLH 2773/4885 |
| US-20060088610-A1 | Anti-inflammatory cranberry flavonol extract preparations | LGALS3, FUT6, GALNT6 | CYP3A4 1687/4885CYP2D6 461/4885POLH 2773/4885 |
| US-20110195138-A1 | Anti-inflammatory cranberry flavonol extract preparations | LGALS3, FUT6, GALNT6 | CYP3A4 1687/4885CYP2D6 461/4885POLH 2773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.